Eli Lilly and Company (LLY) Rewrites Drug R&D Rule Book
10/11/2013 10:16:03 AM
Last week I had the opportunity to get a rare behind the scenes tour of three of Eli Lilly’s (NYSE: LLY) research laboratories — Alzheimer’s Disease (in vivo), Advanced Analytics (in silico), and Automated Synthesis (in vitro), as well as sit in on the company’s investment community update meeting. Having worked in pharma for 17 years, with numerous trips to the corporate headquarters of Mead Johnson Nutritional (NYSE: MJN) in Evansville, IN, and Organon Pharmaceuticals in Roseland, NJ (prior to being acquired by Schering-Plough), I thought I was well prepared for what to expect.
Hey, check out all the research scientist jobs. Post your resume today!